The Panhandle Health District (PHD) recently announced its support of individuals receiving a third dose of the COVID-19 vaccine.
The third dose of Pfizer or Moderna COVID-19 vaccines have been approved by the U.S. Food and Drug Administration (FDA) and the CDC for use by individuals with weakened immune systems.
Individuals who’ve been receiving active cancer treatment for tumors or cancers of the blood, have received an organ transplant and are taking medicine to suppress the immune system, have received a stem cell transplant within the last two years or are taking medicine to suppress the immune system are encouraged to take a third dose of the COVID-19 vaccine.
Additionally those with moderate or severe primary immunodeficiency such as DiGeorge syndrome or Wiskott-Aldrich syndrome, individuals with advanced or untreated HIV infection and those active in treatments with high-dose corticosteroids or other drugs that may suppress your immune response are also eligible.
“People should talk to their healthcare provider about their medical condition, and whether getting an additional dose is appropriate for them,” PHD Public Information Officer Katherine Hoyer wrote in a press release. “A patient’s clinical team is best positioned to determine the degree of immune compromise and appropriate timing of vaccination. The CDC has issued guidance for healthcare providers and the third dose for immunocompromised patients does not require a physician order, vaccine eligibility will be on the ‘honor’ system/ ‘self- attestation.’”
Individuals with immune compromising conditions can schedule their third dose appointment through PHD or other participating providers in the area including the Benewah Community Hospital and Jack’s Pharmacy.
Those interested can call the PHD COVID-19 hotline to schedule their appointment at 877-415-5225.
Hotline hours of operation are 9am-12pm and 1pm-4pm, Monday through Friday.